期刊文献+

EGFL7在人脑胶质瘤中的表达及其意义 被引量:4

Expression of EGFL7 in Human Gliomas and Its Correlation with Glioma Grade
下载PDF
导出
摘要 目的探讨EGFL7基因在人脑胶质瘤组织中的表达及其意义。方法收集36例新鲜胶质瘤标本,其中包括21例低度恶性(Ⅰ-Ⅱ级)及15例高度恶性者(Ⅲ-Ⅳ级),用RT-PCR检测其EGFL7 mRNA的表达。另收集45例胶质瘤石蜡标本,其中包括24例低度恶性(Ⅰ-Ⅱ级)及21例高度恶性者(Ⅲ-Ⅳ级),用免疫组织化学检测EGFL7蛋白的表达情况。并分析EGFL7蛋白表达与胶质瘤病理分级的关系。结果 EGFL7 mRNA及其蛋白在人脑胶质瘤中存在表达,EGFL7蛋白表达主要定位于肿瘤细胞及血管内皮细胞的胞质。其表达与肿瘤的恶性程度有明显的相关性(t=4.399,P〈0.01);EGFL7在正常脑组织中没有表达。结论人脑胶质瘤中肿瘤细胞及其血管内皮细胞EGFL7均呈增高表达并且与其肿瘤恶性程度具有明显相关性,提示EGFL7在胶质瘤的发生发展中发挥重要作用。 Objective To investigate the expression of EGFL7 in human glioma tissues.Methods Fresh tissues of 36 patients with glioma,including 21 cases of low malignance(grade Ⅰ~Ⅱ) and 15 cases of high malignance(grade Ⅲ~Ⅳ),were used in the present study.The expression of EGFL7 mRNA in these glioma tissues was examined by RT-PCR.Other 45 cases of formalin-fixed,paraffin-embedded specimens of glioma,including low 24 cases of malignance(grade Ⅰ~Ⅱ) and 21 cases of high malignance(grade Ⅲ~Ⅳ),were used to assess the expression status of EGFL7 protein by immunohistochemical staining.The correlation between EGFL7 expression and glioma grades was investigated.Results The expression of EGFL7 mRNA and protein with human gliomas was detected.EGFL7 protein located in plasm of tumor cells and endothelial cells,and its expression correlated directly with the degree of malignancy(t=4.399,P0.01).However,it was not detected in normal brain.Conslusion Tumor cells and endothelial cells in human glioma tissues can express EGFL7 gene,and the level of EGFL7 expression directly correlates with the degree of malignancy.It suggested that EGFL7 may contribute to the rapid growth and invasion of gliomas.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第2期148-151,共4页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金资助项目(3097297030672149) 教育部新世纪优秀人才培养计划基金资助项目(教育部科技函NCET-07-0861) 湖南省科技厅资助项目(2009JT3049) 湖南省卫生厅科研基金资助项目(B2010-134)
关键词 类表皮生长因子域7 人脑胶质瘤 病理分级 Epidermal growth factor-like domain7 Human glioma Glioma grade
  • 相关文献

参考文献16

  • 1Fukumura D,Jain RK. Tumor microvaseulature and microenvironment:targets for anti-angiogenesis and normalization[J]. Microvasc Res, 21)07,74 (2-3) : 72-84.
  • 2张倜,孙惠川,汤钊猷.肿瘤血管异质性及其研究意义[J].国外医学(肿瘤学分册),2005,32(2):94-97. 被引量:4
  • 3Ribatti D,Nico B,Crivellato E,et al. The structure of the vascular network of tumors [J]. Cancer Lett, 2007,248 ( 1 ) : 18- 23.
  • 4Schmidt M,De Maziere A,Smyczek T,et al. The role of Egf17 in vascular morphogenesis[J]. Novartis Found Syrup, 2007, 283:18-28, discussion 28-36,238-241.
  • 5Hayes DF, Miller K, Sledge G. Angiogenesis as targeted breast cancer therapy[J]. Breast,2007,16(Suppl 2):17-19.
  • 6Remmele W,Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue[J]. Pathologe, 1987,8(3) : 138-40.
  • 7Ko CD,Kim JS,Ko BG,et al. The meaning of the c-kit protooncogene product in malignant transformation in human mammary epithelium[J]. Clin Exp Metastasis, 2003,20 (7) : 593-7.
  • 8王彦刚,章翔,付洛安,费舟,刘卫平,王占祥,张剑宁.HIF与脑胶质瘤恶性度及侵袭力的关系[J].第四军医大学学报,2003,24(22):2034-2036. 被引量:5
  • 9秦华平,熊光仲,肖惠生.脑胶质瘤中缺氧诱导因子-1α的表达及与肿瘤分级的相关性[J].中华神经医学杂志,2005,4(4):348-350. 被引量:6
  • 10Simiantonaki N, Jayasinghe C, Miehel-Schmidt R, et al. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines[J]. Int J Oncol,2008,32(3) :585-592.

二级参考文献58

  • 1秦华平,熊光仲.缺氧诱导因子-1在胶质瘤中的表达及意义[J].中华神经医学杂志,2004,3(4):318-320. 被引量:4
  • 2[1]Parney IF, Hao C, Petruk KC. Glioma immunology and immunotherapy [ J ]. Neurosurgery, 2000; 46 (4): 778 - 792.
  • 3[2]Mentlein R, Held-Feindt J. Angiogenesis factors in gliomas: A new key to tumour therapy [ J ] ? Naturwissenschaften, 2003; 90 ( 9 ):385 - 394.
  • 4[3]Xiang F, Tanaka J, Fukuda T. Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells[J]. Brain Tumor Pathol, 2001 ;18(2) :67 -71.
  • 5[4]Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth [ J ]. Cancer Res, 2000; 60 ( 15 ):4010 -4015.
  • 6[5]Goda N, Dozier S J, Johnson RS. HIF-1 in cell cycle regulation, apoptosis, and tumor progression [J]. Antioxid Redox Signal, 2003;5(4) :467 -473.
  • 7[6]Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation [ J ]. Mol Cell Biol, 1992; 12 (12): 5447 - 5454.
  • 8[7]Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors:Key transcriptional regulators of hypoxic responses [ J ]. Cell Mol Life Sci, 2003 ;60(7) :1376 - 1393.
  • 9[8]Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R,Richter E, Katschinski DM, Wenger RH. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy [ J ]. Oncogene,2003 ;22(21 ) :3213 -3220.
  • 10[9]Bachtiary B, Schindl M, Potter R, Dreier B, Knocke TH, Hainfellner JA, Horvat R, Birner P. Overexpression of hypoxia-inducible factor 1 alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer [J]. Clin Cancer Res, 2003;9(6) :2234 -2240.

共引文献12

同被引文献41

  • 1Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of turnouts of the central nervous system. Acta Neuropathol, 2007, 114 ( 2 ) : 97 -109.
  • 2Fitch MJ, Campagnolo L, Kuhnert F, et al. Egfl7, a novelepidermal growth factor-domain gene expressed in endothelial ceils. Dev Dyn, 2004, 230(2) :316-324.
  • 3Wu F, Yang LY, Li YF, et al. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocel- lular carcinoma. Hepatology, 2009, 50 ( 6 ) : 1839-1850.
  • 4Nichol D, Stuhlmann H. EGFL7 : a unique angiogenic signa- ling factor in vascular development and disease. Blood, 2012, 119(6) :1345-1352.
  • 5Li JJ, Yang XM, Wang SH, et al. Prognostic role of epider- mal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma. J Laryngol Otol, 2011, 125 (11) :1152-1157.
  • 6Philippin-Lauridant G, Baranzelli MC, Samson C, et al. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer. Int J Oncol, 2013, 42 (4) : 1367-1375.
  • 7Delfortrie S, Pinte S, Mattot V, et al. Egil7 promotes tumor escape from immunity by repressing endothelial cell activation. Cancer Res, 2011, 71(23):7176-7186.
  • 8Gilsohn E, Volk T. Slowdown promotes muscle integrity by modulating integrin-mediated adhesion at the myotendinous junction. Development, 2010, 137 (5) :785-794.
  • 9Nikolic I, Stankovic ND, Bicker F, et al. EGFL7 ligates c:vl33 integrin to enhance vessel formation. Blood, 2013, 121(15) :3041 -3050.
  • 10De Mazire A, Parker L, Van Dijk S, et al. Egfl7 knock- down causes defects in the extension and junctional arrange- ments of endothelial cells during zebrafish vasculogenesis. Dev Dyn, 2008, 237(3) :580-591.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部